These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 1256687)
1. [Controlled clinical trial of 2-mercapto-propionyl-glycine in chronic hepatopathies]. Dioguardi N; Ideo G; De Franchis R; Ronchi G Minerva Med; 1976 Mar; 67(11):676-81. PubMed ID: 1256687 [TBL] [Abstract][Full Text] [Related]
2. [Therapy of hepatic diseases with alpha-mercaptopropionylglycine]. De Pergola E; Carrozzini B; Selvaggio G; De Pergola G Minerva Med; 1982 May; 73(19):1297-9. PubMed ID: 7078808 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the liver cell clearance fraction before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies]. Cortinovis A; Paolini FA; Crippa A Arch Sci Med (Torino); 1979; 136(4):497-508. PubMed ID: 550750 [TBL] [Abstract][Full Text] [Related]
4. [Study of changes in certain immunoglobulin fractions in acute and chronic hepatopathies treated with alpha-mercaptopropionylglycine]. Marinai E; Ulivieri P; Righi A Minerva Med; 1977 Dec; 68(62):4193-7. PubMed ID: 600464 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the changes in some laboratory parameters in liver disease patients treated with Toxepasi Complex]. Lenzi S Minerva Med; 1976 Sep; 67(46):2961-74. PubMed ID: 967362 [TBL] [Abstract][Full Text] [Related]
6. [Histological and ultramicroscopic aspects of the small intestine in aregenerative enteropathies after treatment with 2-mercapto-propionyl-glycine (Thiola)]. Labò G; Gasbarrini G; Barbara L; Fontana G; Corazza GR Minerva Med; 1977 Jul; 68(36):2491-8. PubMed ID: 887228 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of acute and chronic liver disease as well as several malabsorption syndromes with 2 mercaptopropionylglycine MPG (thiola) (author's transl)]. Markoff NG Schweiz Rundsch Med Prax; 1975 Jul; 64(30):958-61. PubMed ID: 1144310 [No Abstract] [Full Text] [Related]
8. [Effect of 2 mercaptopropionylglycine on the cytotoxic activity of lymphocytes from patients with chronic active hepatitis against rabbit hepatocytes isolated and cultured in vitro]. Mazzetti M; Guizzardi G; Meliconi R; Baraldini M; Stancari MV; Mazzoli M; Stefanini GF Boll Soc Ital Biol Sper; 1981 Jul; 57(14):1477-83. PubMed ID: 7295410 [TBL] [Abstract][Full Text] [Related]
9. [Double-blind studies of the therapeutic action of S-Adenosylmethionine (SAMe) in oral administration, in liver cirrhosis and other chronic hepatitides]. Miglio F; Stefanini GF; Corazza GR; D'Ambro A; Gasbarrini G Minerva Med; 1975 May; 66(33):1595-9. PubMed ID: 1095965 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the fraction of hepatocyte depuration before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies]. Cortinovis A; Paolini FA; Crippa A Minerva Med; 1979 Dec; 70(54):3709-13. PubMed ID: 523002 [No Abstract] [Full Text] [Related]
11. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial]. Yin SS; Wang BE; Wang TL; Jia JD; Qian LX Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205 [TBL] [Abstract][Full Text] [Related]
12. The effects of MPG (2-mercapto-propionyl-glycine) in atrophic enteritis and aregenerative enteropathies. Labò G; Gasbarrini G; Barbara L; Fontana G; Corazza GR Panminerva Med; 1977; 19(4):227-35. PubMed ID: 593700 [No Abstract] [Full Text] [Related]
13. [Clinical aspects of cystinuria and its treatment by thiola (author's transl)]. Zechner O; Latal D; Gründig E; Müller M Wien Klin Wochenschr; 1976 Feb; 88(3):101-5. PubMed ID: 960706 [TBL] [Abstract][Full Text] [Related]
14. [The antisteatosic activity of 2-MPG (Thiola). Study with the (BSF) dynamic test and with liver biopsy before and after the treatment]. Surrenti C; Arcangeli A; Casini A Minerva Med; 1978 Dec; 69(61):4251-6. PubMed ID: 733081 [TBL] [Abstract][Full Text] [Related]
15. [Tiopronine, new anti-rheumatic drug, has slow action in rheumatoid arthritis]. Amor B; Mery C; de Gery A Rev Rhum Mal Osteoartic; 1980 Mar; 47(3):157-62. PubMed ID: 7384724 [TBL] [Abstract][Full Text] [Related]
16. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B. Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752 [TBL] [Abstract][Full Text] [Related]
18. Serum gamma-glutamyl transpeptidase: its clinical significance. Pár A; Mestyán I; Kádas I; Balázs M; Gógl A Acta Med Acad Sci Hung; 1976; 33(4):309-19. PubMed ID: 23644 [TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive therapy in chronic liver disease. Sherlock S Minerva Med; 1978 Aug; 69(38):2605-9. PubMed ID: 714260 [TBL] [Abstract][Full Text] [Related]
20. [Relations between protidopoiesis and biological transmethylations: action of S-adenosylmethionine on protein crasis in chronic hepatopathies]. Cantoni L; Maggi G; Mononi G; Preti G Minerva Med; 1975 May; 66(33):1581-9. PubMed ID: 1095963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]